(800) 890-7449
Nationwide Representation
Drugs & Devices
“Bill Curtis is incredibly knowledgeable about how to approach complicated pharmaceutical and product liability cases. When you go to war against these giant drug companies, you want him on your side.” -Ken Suggs, Former President, Assoc. of Trial Lawyers


Curtis Law Group...
Holding Drug-Makers Accountable

          Have you taken Fosamax?   

You may be eligible for compensation.


Symptoms you may be experiencing with Fosamax:


  • Subtrochanteric fractures
  • Diaphyseal femur fractures
  • Chest pain
  • Difficulty or pain when swallowing
  • Pain or burning under the ribs or in the back
  • Severe heartburn, burning pain in your upper stomach, or coughing up blood
  • Severe  joint, bone or muscle pain
  • New or unusual pain in your thigh or hip
  • Jaw pain, numbness, or swelling


Facts about Fosamax:


Fosamax, a popular osteoporosis drug, has been linked to severe musculoskeletal pain (pain of the joints, muscles, and/or bones), as well as a serious bone disease called Osteonecrosis of the Jaw (ONJ), also known as "dead jaw" and "fossy jaw".  An article on the association between Fosamax and ONJ was first  published in the Journal of Oral and Maxillofacial Surgeons, which prompted the US Food and Drug Administration (FDA) to review the safety of Fosamax and other drugs in its class (bisphosphonate drugs). On January 31, 2005, Merck, the manufacturer of Fosamax, received a request for data from the FDA to update the label for Fosamax to include labeling for the jawbone tissue disease. The revised label was not made available until July 2005.

On January 7, 2008, the FDA warned that Fosamax had been linked to severe and sometimes incapacitating bone, joint, and muscle (musculoskeletal) pain.  The agency advised doctors and patients to be aware of this side effect, and to discontinue Fosamax use should it occur.

Fosamax has also been linked to an increased risk of spontaneous femur fractures. Numerous studies have confirmed that long-term use of Fosamax increases the risk of such fractures. Most recently, in February 2011, the Journal of the American Medical Association published a case-control study through which the researchers confirmed that "treatment with a bisphosphonate for more than 5 years was associated with an increased risk of subtrochanteric or femoral shaft fractures." Three months later, the New England Journal of Medicine published a study which revealed that Fosamax patients had a greater than 3000% risk of sustaining atypical femur fractures when compared to those who did not take Fosamax.


Are you eligible to receive compensation?


Request a FREE consultation NOW.  We don’t get paid until YOU get paid.  Curtis Law Group serves clients nationwide and we win cases.  To discuss the harm this dangerous drug or medical device may have caused you and your family, call us toll free at 800.890.7449.  You may also contact us by email now for prompt attention to your questions.